Rxo (RXO) Operating Leases (2021 - 2026)

Rxo has reported Operating Leases for 6 years, with the latest figure at $182.0 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 9.45% year-over-year to $182.0 million; the trailing twelve-month figure through Mar 2026 stood at $182.0 million (down 9.45% YoY), and the FY2025 full-year result was $191.0 million, down 35.47% from the prior year.
• Operating Leases for Q1 2026 stood at $182.0 million, down from $191.0 million in the prior quarter.
• The five-year high for Operating Leases was $296.0 million in Q4 2024, with the low at $109.0 million in Q1 2023.
• Historically, Operating Leases has averaged $171.7 million across 5 years, with a median of $160.0 million in 2024.
• Annual changes were most pronounced in 2024 — Operating Leases surged 108.8% — and 2025, when it plunged 35.47%.
• Rxo's Operating Leases stood at $114.0 million in 2022, then gained by 28.07% to $146.0 million in 2023, then surged by 102.74% to $296.0 million in 2024, then sank by 35.47% to $191.0 million in 2025, then dropped by 4.71% to $182.0 million in 2026.
• The last three Operating Leases figures came in at $182.0 million (Q1 2026), $191.0 million (Q4 2025), and $202.0 million (Q3 2025), per Business Quant data.